David Sher/utsouthwestern.edu
Apr 21, 2025, 08:59
David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma
ASTRO shared a post on X:
“Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study by David Sher, et al.
Read about it in the Red Journal.”
David Sher, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service, reshared the post on X, adding:
“In this paper, we analyzed the UTSW Radiation Oncology experience with adapt-on-demand for H&N squamous cell carcinoma using the Varian Ethos system.
TL/DR: Significant (and I think meaningful) improvement in coverage and homogeneity, but no clinically impactful reduction in OAR doses.”
Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.
Authors: Julia J. Shi, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 20:24
Aug 28, 2025, 20:04
Aug 28, 2025, 20:00
Aug 28, 2025, 19:40
Aug 28, 2025, 19:29
Aug 28, 2025, 19:07